SCHEMBL19645362

SCHEMBL19645362

CC(=O)NC(CN1CCOCC1)C(O)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
MAPT P10636 3/20 0.69
UGCG Q16739 2/20 0.69
TP53 P04637 2/20 0.69
MAPK1 P28482 2/20 0.69
CYP3A4 P08684 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C9 P11712 1/20 0.69
NFKB1 P19838 1/20 0.69
CYP2C19 P33261 1/20 0.69
HIF1A Q16665 1/20 0.69
MTOR P42345 1/20 0.69
LMNA P02545 4/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
GMNN O75496 1/20 0.67
BLM P54132 1/20 0.67
PMP22 Q01453 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
ALDH1A1 P00352 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12091630 1.00 MEN1 (0.69) MEN1KMT2AMAPTUGCGTP53
SCHEMBL16938510 1.00 MEN1 (0.69) MEN1KMT2AMAPTUGCGTP53
SCHEMBL12091628 1.00 MEN1 (0.69) MEN1KMT2AMAPTUGCGTP53
SCHEMBL5553004 0.91 MEN1 (0.69) MEN1KMT2AMAPTUGCGTP53
SCHEMBL19354949 0.89 UGCG (0.55) MEN1KMT2AMAPTUGCGTP53
SCHEMBL12091640 0.88 UGCG (0.67) MEN1KMT2AMAPTUGCGTP53
SCHEMBL13417389 0.88 UGCG (0.67) MEN1KMT2AMAPTUGCGTP53
SCHEMBL13569487 0.88 UGCG (0.67) MEN1KMT2AMAPTUGCGTP53
SCHEMBL7096768 0.86 KMT2A (0.61) MEN1KMT2AMAPTUGCGTP53
SCHEMBL6548257 0.85 KMT2A (0.69) MEN1KMT2AMAPTUGCGTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828349-B2 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity EXONHIT THERAPEUTICS SA (FR) 2017-11-28 US disclosed